The ResMed Inc (ASX: RMD) share price has quietly staged a strong comeback over the past year.
After a sharp sell-off in 2023 sparked by concerns over weight-loss drugs impacting sleep apnoea treatment demand, sentiment has shifted.
The sleep disorder treatment company’s shares are up 21% in the last 12 months. This leaves them trading a touch short of their 52-week high of $40.75.
So, with its share price edging closer to a new high, investors may be wondering: Is ResMed still cheap?
Let’s look at what the numbers and the brokers say.
Image source: Getty Images
What is being said about the ResMed share price?
The good news is that the broker community agrees that it isn’t too late to buy the company’s shares.
In fact,…
